Morten Lapin

523 total citations
15 papers, 359 citations indexed

About

Morten Lapin is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Morten Lapin has authored 15 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 10 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Morten Lapin's work include Cancer Genomics and Diagnostics (12 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Cancer Cells and Metastasis (5 papers). Morten Lapin is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Cancer Cells and Metastasis (5 papers). Morten Lapin collaborates with scholars based in Norway, United States and France. Morten Lapin's co-authors include Oddmund Nordgård, Kjersti Tjensvoll, Bjørnar Gilje, Satu Oltedal, Rune Smaaland, Milind Javle, Jon Arne Søreide, Herish Garresori, M. M. Javle and Nils Glenjen and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Morten Lapin

15 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morten Lapin Norway 8 299 233 134 121 35 15 359
Eirini Biziota Greece 8 147 0.5× 158 0.7× 151 1.1× 76 0.6× 29 0.8× 18 319
Isabel Heidrich Germany 8 192 0.6× 172 0.7× 128 1.0× 67 0.6× 42 1.2× 18 321
Núria Jordana‐Ariza Spain 7 193 0.6× 129 0.6× 119 0.9× 139 1.1× 41 1.2× 12 262
Mercedes Rodríguez-Garrote Spain 8 176 0.6× 201 0.9× 77 0.6× 58 0.5× 24 0.7× 11 252
Xue-Rui Ye China 2 239 0.8× 140 0.6× 158 1.2× 162 1.3× 27 0.8× 8 330
Yvonne H. C. M. Smolders Netherlands 5 290 1.0× 154 0.7× 140 1.0× 140 1.2× 82 2.3× 7 350
Eisaku Furukawa Japan 5 184 0.6× 173 0.7× 99 0.7× 78 0.6× 80 2.3× 7 274
Ros Cutts United Kingdom 9 209 0.7× 296 1.3× 116 0.9× 268 2.2× 37 1.1× 15 431
Robin Brenner United States 5 205 0.7× 286 1.2× 104 0.8× 70 0.6× 20 0.6× 12 366
Itziar de Aguirre Spain 9 140 0.5× 155 0.7× 193 1.4× 178 1.5× 68 1.9× 21 388

Countries citing papers authored by Morten Lapin

Since Specialization
Citations

This map shows the geographic impact of Morten Lapin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morten Lapin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morten Lapin more than expected).

Fields of papers citing papers by Morten Lapin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morten Lapin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morten Lapin. The network helps show where Morten Lapin may publish in the future.

Co-authorship network of co-authors of Morten Lapin

This figure shows the co-authorship network connecting the top 25 collaborators of Morten Lapin. A scholar is included among the top collaborators of Morten Lapin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morten Lapin. Morten Lapin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Lapin, Morten, Kjersti Tjensvoll, Satu Oltedal, et al.. (2023). Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer. Clinical Cancer Research. 29(7). 1267–1278. 20 indexed citations
2.
Tjensvoll, Kjersti, Satu Oltedal, Ingvild Dalen, et al.. (2023). Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals disease progression earlier than radiological imaging. Molecular Oncology. 17(9). 1857–1870. 5 indexed citations
3.
Lapin, Morten, et al.. (2023). Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer. PLoS ONE. 18(9). e0291623–e0291623. 6 indexed citations
4.
Tjensvoll, Kjersti, Morten Lapin, Bjørnar Gilje, et al.. (2022). Novel hybridization- and tag-based error-corrected method for sensitive ctDNA mutation detection using ion semiconductor sequencing. Scientific Reports. 12(1). 5816–5816. 2 indexed citations
5.
Nordgård, Oddmund, Morten Lapin, Kjersti Tjensvoll, et al.. (2022). Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: a prospective observational study. BMC Cancer. 22(1). 609–609. 2 indexed citations
6.
Gouda, Mohamed A., Dzifa Y. Duose, Morten Lapin, et al.. (2022). Mutation-Agnostic Detection of Colorectal Cancer Using Liquid Biopsy-Based Methylation-Specific Signatures. The Oncologist. 28(4). 368–372. 7 indexed citations
7.
Nordgård, Oddmund, Morten Lapin, Bjørn Henning Grønberg, et al.. (2021). Liquid Biopsies in Solid Cancers: Implementation in a Nordic Healthcare System. Cancers. 13(8). 1861–1861. 8 indexed citations
8.
Øvestad, Irene Tveiterås, Birgit Engesæter, Mari K. Halle, et al.. (2021). High-Grade Cervical Intraepithelial Neoplasia (CIN) Associates with Increased Proliferation and Attenuated Immune Signaling. International Journal of Molecular Sciences. 23(1). 373–373. 11 indexed citations
9.
Lapin, Morten, Helen J. Huang, Milind Javle, et al.. (2020). Abstract 734: Monitoring of dynamic changes and clonal evolution in circulating tumor DNA from patients with IDH-mutated cholangiocarcinoma treated with IDH inhibitors. Cancer Research. 80(16_Supplement). 734–734. 1 indexed citations
10.
Lapin, Morten, Satu Oltedal, Kjersti Tjensvoll, et al.. (2018). Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer. Journal of Translational Medicine. 16(1). 300–300. 93 indexed citations
11.
Lapin, Morten, Kjersti Tjensvoll, Satu Oltedal, et al.. (2017). Single-cell mRNA profiling reveals transcriptional heterogeneity among pancreatic circulating tumour cells. BMC Cancer. 17(1). 390–390. 32 indexed citations
12.
Lapin, Morten, Kjersti Tjensvoll, Satu Oltedal, et al.. (2016). MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment. Scientific Reports. 6(1). 28929–28929. 34 indexed citations
13.
Swensen, Jeffrey, Morten Lapin, Bárbara Guerra, et al.. (2016). The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in Cancer. PLoS Genetics. 12(5). e1006039–e1006039. 19 indexed citations
14.
Tjensvoll, Kjersti, Morten Lapin, Satu Oltedal, et al.. (2015). Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer. Molecular Oncology. 10(4). 635–643. 118 indexed citations
15.
Tjensvoll, Kjersti, Morten Lapin, Satu Oltedal, et al.. (2015). Abstract 5241: Clinical relevance of circulating tumor DNA in plasma from pancreatic cancer patients. Cancer Research. 75(15_Supplement). 5241–5241. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026